2,628
Views
18
CrossRef citations to date
0
Altmetric
Editorial

Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities

Pages 751-754 | Received 28 Dec 2015, Accepted 29 Feb 2016, Published online: 25 Mar 2016

References

  • Tsang A, Von Korff M, Lee S, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008;9(10):883–891.
  • Johannes CB, Le TK, Zhou X, et al. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain. 2010;11(11):1230–1239.
  • Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302:123.
  • Agency for Health Care Quality and Research. Acute pain management: operative or medical procedures and trauma, part 1. Clin Pharmacol. 1992;11:309–331.
  • Agency for Health Care Quality and Research. Acute pain management: operative or medical procedures and trauma, part 2. Clin Pharmacol. 1992;11:391–414.
  • CDC. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR. 2011;60(43):1487–1492.
  • Frenk SM, Porter KS, Paulozzi LJ. Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief. 2015 Feb;(189):1–8.
  • Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA. 2007 Jan 17;297(3):249–251.
  • Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013 Feb 20;309(7):657–659.
  • Substance abuse and mental health services administration, center for behavioral health statistics and quality. . In: Treatment episode data set (TEDS): 2001-2011. National admissions to substance abuse treatment services. BHSIS Series S-65, HHS Publication No. (SMA) 13-4772. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2013.
  • Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.
  • Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9:444–459.
  • Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007 Jan 16;146(2):116–127.
  • Cheatle MD, O’Brien CP. Opioid therapy in patients with chronic noncancer pain: diagnostic and clinical challenges. Adv Psychosom Med. 2011;30:61–91.
  • Smith SM, Dart RC, Katz NP, et al. Analgesic, anesthetic, and addiction clinical trials, translations, innovations, opportunities, and networks (ACTTION) public-private partnership. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013 Nov;154(11):2287–2296.
  • Vowles KE, McEntee ML, Julnes PS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015 Apr;156(4):569–576.
  • Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30(3):185–194.
  • Boscarino JA, Hoffman SN, Han JJ. Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates. Subst Abuse Rehabil. 2015 Aug 19;6:83–91.
  • Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432–442.
  • Butler S, Budman S, Fernandez K, et al. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004 Nov;112(1–2):65–75.
  • Cheatle M, Barker C. Improving opioid prescription practices and reducing patient risk in the primary care setting. J Pain Res. 2014;7:301–311.
  • Cicero TJ, Ellis MS. Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from Oxycontin. JAMA Psychiatry. 2015 May;72(5):424–430.
  • Dart RC, Severtson SG, Bucher-Bartelson B. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015 Apr 16;372(16):1573–1574.
  • IOM (Institute of Medicine). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington (DC): National Academies Press; 2011.
  • Gatchel RJ, McGeary DD, McGeary CA, et al. Interdisciplinary chronic pain management: past, present, and future. Am Psychol. 2014 Feb-Mar;69(2):119–130.
  • Schatman ME. Interdisciplinary chronic pain management: international perspectives. ISAP Pain Clin Updat. 2012;XX(7):1–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.